Abstract

Cardiac Arrest Induced by Anti-Bradycardia and Anti-Tachycardia Therapies of an Implantable Cardioverter Defibrillator

Implantable cardioverter-defibrillators (ICD) can terminate ventricular tachy-arrhythmias (VTs) with shocks or antitachycardia pacing (ATP). Lots of studies demonstrated that ATP terminates most of VTs but with a 1% to 7% risk of acceleration or precipitation of these arrhythmias. Also, anti-bradycardia therapy can have an intrinsic arrythmogenic risk.


Author(s):

Mauro Toniolo, Elisabetta Daleffe, Luca Rebellato, Domenico Facchin and Alessandro Proclemer



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • 36th Cardiovascular Nursing & Nurse Practitioners Meeting
    July 10-11, 2017 Chicago, USA
  • 19th Annual Cardiology Congress
    August 31-September 01, 2017 Philadelphia, USA
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat